ArticleCureus2024

Exceptional and Sustained Response to Belzutifan in Von Hippel-Lindau Disease-Associated Central Nervous System Hemangioblastoma.

Mousa Thalji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.